New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, 350002, People's Republic of China.
Chem Asian J. 2024 Jun 3;19(11):e202400268. doi: 10.1002/asia.202400268. Epub 2024 May 6.
Photodynamic therapy (PDT) as an emerging therapeutic method has drawn much attention in the treatment field for cancer. Photosensitizer, which can convert photon energy into cytotoxic species under light irradiation, is the core component in PDT. The design of photosensitizers still faces problems of light absorption, targeting, penetration and oxygen dependence. With the rapid progress of material science, various photosensitizers have been developed to produce cytotoxic species for treatment of tumor with high selectivity, safety, and noninvasiveness. Besides, the applications of photosensitizers have been expanded to diverse cancer treatments such as drug release, optogenetics and immune checkpoint blockade. In this review, we summarize the recent advances of photosensitizers in various therapeutic methods for cancer. Prevailing challenges and further prospects associated with photosensitizers are also discussed.
光动力疗法(PDT)作为一种新兴的治疗方法,在癌症治疗领域引起了广泛关注。光动力疗法的核心组成部分是光敏剂,它可以在光照射下将光子能量转化为细胞毒性物质。然而,光敏剂的设计仍然面临着光吸收、靶向性、穿透性和氧气依赖性等问题。随着材料科学的快速发展,各种光敏剂已经被开发出来,用于产生细胞毒性物质,以实现对肿瘤的高选择性、安全性和非侵入性治疗。此外,光敏剂的应用已经扩展到多种癌症治疗方法,如药物释放、光遗传学和免疫检查点阻断。在本文中,我们总结了光敏剂在各种癌症治疗方法中的最新进展,并讨论了与之相关的现存挑战和未来展望。